Evidence map›Paper›PMID 25228314›Full record

ArticleJournal of innate immunity2015

Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.

Asaf Wilensky, Rinat Tzach-Nahman, Jan Potempa, Lior Shapira, Gabriel Nussbaum

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Testosterone Modulates Virulence-Associated Phenotypes ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Frontiers in immunology · 2026
    Article
  5. Cancers · 2025
    Review
  6. Article
  7. Article
  8. Insights Into the Mechanism of Action of Chlorhexidine onInternational journal of dentistry · 2025
    Article
  9. Oral Pathobiont-Derived Outer Membrane Vesicles in the Oral-Gut Axis.International journal of molecular sciences · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Frontiers in immunology · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Macrophages: A communication network linkingFrontiers in immunology · 2022
    Review
  20. Shut-Down of Type IX Protein Secretion Alters the Host Immune Response toFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Asaf Wilensky *Department of Periodontology , Faculty of Dental Medicine, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
Rinat Tzach-Nahman *Department of Periodontology , Faculty of Dental Medicine, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
Jan PotempaCenter of Oral Health and Systemic Disease, School of Dentistry, University of Louisville, KY, USA.
Lior Shapira *Department of Periodontology , Faculty of Dental Medicine, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
Gabriel Nussbaum *Institute of Dental Sciences, Faculty of Dental Medicine, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
Hadassah Medical Center · ILHebrew University of Jerusalem · ILJagiellonian University · PL

Funding

BACTERIAL PROTEINASES IN PERIODONTAL DISEASER01DE009761 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 1991 to 2012
$3.8M
Bacterial peptidylarginine deiminase, a link between gums and joint diseaseR01DE022597 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2023
$3.7M
NIDCR NIH HHS DE009761NIDCR NIH HHS DE022597NIDCR NIH HHS R01 DE009761NIDCR NIH HHS R01 DE022597
6 · The paper itself

Abstract

Cysteine proteases (gingipains) from Porphyromonas gingivalis are key virulence factors in chronic periodontitis. Innate immune receptors CD14, Toll-like receptor (TLR) 2 and TLR4 are important in P. gingivalis recognition. We examined the ability of gingipains to cleave CD14, TLR2 and TLR4, and the consequences for the cellular response to bacterial challenge. Macrophages were exposed to Arg (RgpA and RgpB)- and Lys (Kgp)-gingipains, and residual expression of TLR2, TLR4 and CD14 was determined by flow cytometry. The cellular response to live bacteria following exposure to purified gingipains was evaluated by TNFα production and bacterial phagocytosis. RgpA and Kgp decreased CD14 detection in a concentration (p = 0.0000002)- and time (p = 0.03)-dependent manner, whereas RgpB had no significant effect. TLR2 and TLR4 expression were unaffected. Reduction in CD14 expression was more efficient with Lys-gingipain than with Arg-gingipain. A reduced CD14 surface level correlated with decreased TNFα secretion and bacterial phagocytosis following challenge with live P. gingivalis, but the response to heat-killed bacteria was unaffected. Therefore, gingipains reduce CD14 expression without affecting expression of the bacterial-sensing TLRs. Reduced CD14 expression depends on the gingipain hemagglutinin/adhesion site and results in macrophage hyporesponsiveness to bacterial challenge. Further studies are needed to determine if reduced CD14 expression is linked to periodontitis induced by P. gingivalis.

Indexed as

AnimalsBacterial AdhesionBacterial ProteinsBacteroidaceae InfectionsCells, CulturedChronic PeriodontitisCysteine ProteasesDown-RegulationFemaleHumansImmunity, CellularImmunity, InnateLipopolysaccharide ReceptorsMacrophagesMiceMice, Inbred BALB CBacterial ProteinsCysteine ProteasesLipopolysaccharide ReceptorsTlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alphaVirulence Factors

Identifiers

PMID25228314
PMCPMC4348206
OpenAlexW1974224407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.